Thursday, April 3, 2025
Home > Phase (Page 2)

Crypto platform Nexo to Phase Out Cashback for Exchange and Card Transactions in the UK

"Nexo is committed to our U.K. community, and we regard our compliance responsibilities with the highest priority, reflecting our aim of nurturing a robust crypto ecosystem," a company spokesperson said. "Additionally, our enhanced interface epitomizes our dedication to a consistent user experience in the evolving financial advertising context." Source

Read More

Tether launches testing phase for Bitcoin mining platform

Paolo Ardoino, chief technology officer of Tether, announced the launch of the testing phase for Moria, the company’s Bitcoin mining platform. In a posting on X (formerly Twitter), Ardoino declared the platform has achieved a significant milestone during this phase by deploying its initial batch of containers and miners, including extended

Read More

Cronos Labs begins recruitment phase for $100M accelerator program

Web3 startup accelerator Cronos Labs has launched the third cohort of its accelerator program, which aims to support early-stage projects by providing funding opportunities and mentorship. The scheme is backed by $100 million in investment that will be used to support crypto startups.In an announcement sent to Cryptox, Cronos Labs

Read More

Immutable zkEVM begins testnet phase with 12 Web3 games in development

Web3 gaming platform Immutable has commenced public testing of its Immutable zkEVM in collaboration with Polygon Labs.Work on the zero-knowledge Ethereum virtual machine (zkEVM) network began in March after Immutable announced a partnership with Polygon Labs. Polygon's own 'holy grail' Ethereum-scaling zkEVM hit mainnet on March 27. In an Aug. 14 announcement,

Read More

Elon Musk’s Neurotech Company Neuralink Seeks Partner to Begin Human Trials Phase

Neuralink is looking for a partner to conduct human trials for brain implants and has approached a leading neurological treatment centre. Elon Musk‘s brain implant company Neuralink is reportedly searching for a human trials partner and is in talks with several medical centers. Among these is the Arizona-based neurological disease treatment and

Read More